Skip to main content Accessibility help
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2008
  • Online publication date: August 2009

12 - Brain metastases



Brain metastasis is the commonest intracranial tumor in adults. In the United States, approximately 170 000 patients are diagnosed with brain metastases every year (Greenberg et al., 1999; Mehta & Tremont-Lukas, 2004). The rise in incidence is attributed to a number of factors including increased life expectancy, improved control of systemic disease, and better imaging capabilities that facilitate diagnosis of smaller lesions (Wen et al., 2001). While it is recognized that the overall prognosis of these patients remains poor, newer treatment methods have led to improved survival in subsets of patients. Patients with brain metastases often suffer from a variety of neurological, cognitive, and emotional difficulties. It is known that even subtle impairments of cognitive function can adversely affect the quality of life, an issue that was largely ignored earlier due to the dismal outcome. However, in the changing scenario of improved survival, recognizing the effects of the disease and its therapies on neurocognitive outcomes is important in formulating treatment modifications and strategies for rehabilitation that will enable patients to maximize their functional ability. This chapter briefly reviews the incidence and management of brain metastases as relevant to neurocognitive problems in cancer patients, discusses the etiology and pathogenesis of cognitive deficits in these patients, and suggests preventive and therapeutic strategies based on current understanding.

Overview of brain metastases


Brain metastasis is a major debilitating complication affecting cancer patients. Autopsy data indicate that approximately 24% of adult cancer patients develop metastatic brain disease during the course of their cancer (Posner, 1995).

Abrey, , Olson, JD, Raizer, JJet al. (2001). A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J Neurooncol 53: 259–265.
Agboola, O, Benoit, B, Cross, Pet al. (1998). Prognostic factors derived from recursive partitioning analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases. Int J Radiat Oncol Biol Phys 42: 155–159.
Ahles, TA, Saykin, AJ, Furstenberg, CTet al. (2002). Neuropsychologic impact of standard dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20: 485–493.
Alexander, E, Loeffler, JS (1999). The case for radiosurgery. Clin Neurosurg 45: 32–40.
Andrews, DW, Scott, CB, Sperduto, PWet al. (2004). Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet 363(9422): 1665–1672.
Antonadou, D, Coliarakis, N, Paraskevaidis, Met al. (2002a). Whole brain radiotherapy alone or in combination with temozolomide for brain metastases. A phase III study [abstract]. Int J Radiat Oncol Biol Phys 54: 93–94.
Antonadou, D, Paraskevaidis, M, Sarris, Get al. (2002b). Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 20: 3644–3650.
Aoyama, H, Shirato, H, Tago, Met al. (2006). Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. J Am Med Assoc 295(25): 2483–2491.
Arriagada, R, LeChevalier, T, Borie, Fet al. (1995). Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. J Natl Cancer Inst 87: 183–190.
Bambakidis, NC, Miller, RH (2004). Transplantation of oligodendrocyte precursors and sonic hedgehog results in improved function and white matter sparing in the spinal cords of adult rats after contusion. Spine J 4(1):16–26.
Blakemore, WF, Gilson, JM, Crang, AJ (2003). The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors. Exp Neurol 184(2): 955–963.
Boldrey, E, Sheline, G (1967). Delayed transitory clinical manifestation after radiation treatment of intracranial tumors. Acta Radiol 5: 5–10.
Borgelt, B, Gelber, R, Kramer, Set al. (1980). The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6: 1–9.
Borgelt, B, Gelber, R, Larson, Met al. (1981). Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 7: 1633–1638.
Bradley, KA, Mehta, MP (2004). Management of brain metastases. Semin Oncol 31: 693–701.
Breneman, JC, Warnick, RE, Albright, REJet al. (1997). Stereotactic radiosurgery for the treatment of brain metastases. Results of a single institution series. Cancer 79: 551–557.
Brezden, CB, Phillips, KA, Abdolell, M (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18: 2695–2701.
Burger, PC, Mahaley, MS, Dudka, Let al. (1979). The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer 44: 1256–1279.
Cammer, W (2000). Effects of TNFalpha on immature and mature oligodendrocytes and their progenitors invitro. Brain Res 864(2): 213–219.
Cappuzo, F, Mazzoni, F, Maestri, Aet al. (2000). Medical treatment of brain metastases from solid tumors. Forum (Genova) 10: 137–148.
Chatani, M, Teshima, T, Hata, Ket al. (1986). Prognostic factors in patients with brain metastases from lung carcinoma. Strahlenther Onkol 162: 157–161.
Chatani, M, Matayoshi, Y, Masaki, Net al. (1994). Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase. Strahlenther Onkol 170: 155–161.
Chougule, PB, Burton-Williams, M, Saris, Set al. (2000). Randomized treatment of brain metastases with gamma knife radiosurgery, whole brain radiotherapy or both [abstract]. Int J Radiat Oncol Biol Phys 48: 114
Chow, BM, Li, YQ, Wong, CS. (2000). Radiation-induced apoptosis in the adult central nervous system is p53-dependent. Cell Death Differ 7(8): 712–720.
Christodoulou, C, Bafaloukos, D, Kosmidis, Pet al. (2001). Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. Ann Oncol 12: 249–254.
Crossen, JR, Garwood, D, Glatstein, Eet al. (1994). Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation induced encephalopathy. J Clin Oncol 12: 627–642.
Curran, W, Mehta, MP, Terhaard, Cet al. (2002). Predictors of Survival for Patients with Brain Metastases: Results of a Randomized Phase III Trial [abstract 155]. Int J Radiat Oncol Biol Phys 54: 93.
Danysz, W, Parsons, CG, Mobius, JHet al. (2000). Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease: a unified glutamatergic hypothesis on the mechanism of action. Neurotoxicity Res 2: 85–97.
DeAngelis, LM, Delattre, JY, Posner, JB (1989). Radiation induced dementia in patients cured of brain metastases. Neurology 39: 789–796.
Dropcho, EJ (2005). Paraneoplastic disorders of the nervous system. In Black, PM, Loeffler, JS (eds.) Cancer of the Nervous System, (pp. 691–714). Philadelphia, PA: Lippincott Williams & Wilkins.
Ellis, R, Gregor, A (1998). The treatment of brain metastases from lung cancer. Lung Cancer 20: 81–84.
Feldman, H, Gauthier, S, Hecker, Jet al. (2005). Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized placebo-controlled trial. Int J Geriatr Psychiatry 20(6): 559–569.
Fontanella, M, Perozzo, P, Ursone, Ret al. (2003). Neuropsychological assessment after microsurgical clipping or endovascular treatment for anterior communicating artery aneurysm. Acta Neurochir 145: 867–872.
Freidman, MA, Meyers, CA, Sawaya, R (2003). Neuropsychological effects of third ventricular tumor surgery. Neurosurgery 52: 791–798.
Gaspar, L, Scott, C, Rotman, Met al. (1997). Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37(4): 745–751.
Gottwald, B, Wilde, B, Mihajlovic, Zet al. (2004). Evidence for distinct cognitive deficits after focal cerebellar lesions. J Neurol Neurosurg Psychiatry 75: 1524–1531.
Graus, F, Walker, RW, Allen, JC (1983). Brain metastases in children. J Pediatr 103(4): 558–561.
Green, HJ, Pakenham, KI, Headley, BCet al. (2002). Altered cognitive function in men treated for prostate cancer with luteinising hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. Br J Urol 90: 427–432.
Greenberg, H, Chandler, WF, Sandler, HM (1999). Brain metastases. In: Greenberg, H, Chandler, WF, Sandler, HM (eds.) Brain Tumors, (pp. 299–317, Vol. 54). New York: Oxford University Press.
Gregor, A, Cull, A, Stephens, RJet al. (1997). Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicenter randomized trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organisation for Research and Treatment of Cancer (EORTC). Eur J Cancer 33: 1752–1758.
Grill, J, Viguier, D, Kieffer, Vet al. (2004). Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage. J Neurosurg 101: 152–158.
Groves, AK, Barnett, SC, Franklin, RJet al. (1993). Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 362(6419): 453–455.
Haie-Meder, C, Pellae-Cosset, B, Laplanche, Aet al. (1993). Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases. Radiother Oncol 26: 111–116.
Harwood, AR, Simson, WJ (1977). Radiation therapy of cerebral metastases: a randomized prospective clinical trial. Int J Radiat Oncol Biol Phys 2: 1091–1094.
Herman, MA, Tremont-Lukats, I, Meyers, CAet al. (2003). Neurocognitive and functional assessment of patients with brain metastases. Am J Clin Oncol 26(3): 273–279.
Hoerr, R (2003). Behavioral and psychological symptoms of dementia (BPSD): effects of EGb 761. Pharmacopsychiatry 36 [Suppl. 1]: S56–S61.
Hulshof, MC, Stark, NM, Kleij, Aet al. (2002). Hyperbaric oxygen therapy for cognitive disorders after irradiation of the brain. Strahlenther Onkol 178(4): 192–198.
Hutter, BO, Spetzger, U, Bertalanffy, Het al. (1997). Cognition and quality of life in patients after transcallosal microsurgery for midline tumors. J Neurosurg Sci 41: 123–129.
Izquierdo, I, da Cunha, C, Rosat, Ret al. (1992). Neurotransmitter receptors involved in post-training memory processing by the amygdala, medial septum, and hippocampus of the rat. Behav Neural Biol 58(1): 16–26.
Jatoi, A, Kahanic, SP, Frytag, Set al. (2005). Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs. Support Care Cancer 13(1): 66–69.
Juengling, FD, Ebert, D, Gut, Oet al. (2000). Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology (Berl) 152: 383–389.
Karatekin, C, Lazareff, JA, Asarnow, RF (2000). Relevance of cerebellar hemispheres for executive functions. Pediatr Neurol 22: 106–112.
Kauer, JA, Manlenka, RC, Nicoll, RA (1988). NMDA application potentiates synaptic transmission in the hippocampus. Nature 334(6179): 250–252.
Kelly, K, Bunn, PAJ (1998). Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer? Lung Cancer 20: 85–91.
Kelley, KW, Bluthé, RM, Dantzer, Ret al. (2003). Cytokine-induced sickness behavior. Brain Behav Immun 17: S112–S118.
Kershner, P, Wang-Cheng, R (1989). Psychiatric side-effects of steroid therapy. Psychosomatics 30: 135–139.
Klein, M, Engelberts, NHJ, Ploeg, HMet al. (2003). Epilepsy in low grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54: 514–520.
Knighton, , Hunt, TK, Schenestuhl, Het al. (1983). Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 221: 1283–1289.
Kohshi, K, Imada, H, Nomoto, Set al. (2003). Successful treatment of radiation-induced brain necrosis by hyperbaric oxygen therapy. J Neurol Sci 209(1–2): 115–117.
Komaki, R, Meyers, CA, Shin, DMet al. (1995). Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 33(1): 179–182.
Kondzoilka, D, Patel, A, Lunsford, LDet al. (1999). Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45(2): 427–434.
Kramer, S (1968). The hazards of therapeutic irradiation of the central nervous system. Clin Neurosurg 15: 301–318.
Kurtz, JM, Gelber, R, Brady, LWet al. (1981). The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 7: 891–895.
Lassman, AB, DeAngelis, LM (2003). Brain metastases. Neurol Clin 21(I): I,vii.
LeBars, PL (2003). Response patterns of EGb 761 in Alzheimer's disease: influence of neuropsychological profiles. Pharmacopsychiatry Jun; 36 [Suppl 1]: S44–S49.
Lee, AW, Kwong, DLW, Leung, SFet al. (2002). Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time. Int J Radiat Oncol Biol Phys 53: 75–85.
Levin, ED, Sledge, D, Baruah, Aet al. (2003). Ventral hippocampal NMDA blockade and nicotinic effects on memory function. Brain Res Bull 61(5): 489–495.
Leyland-Jones, B, Semiglazov, V, Pawlicki, Met al. (2005). Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J Clin Oncol 23: 5960–5972.
Li, J, Bentzen, SM, Renschler, M, Mehta, MP (2006). Improvement in neurocognitive function (NCF) correlates with tumor regression after whole brain radiation therapy (WBRT) for brain metastases (BM) [abstract]. Proc Am Soc Clin Oncol 24 [Suppl. 18S]: 1504.
Lilja, A, Smith, GJ, Salford, LG (1992). Microprocesses in perception and personality. J Nerv Ment Dis 180: 82–88.
Lim, LC, Rosenthal, MA, Maartens, Net al. (2004). Management of brain metastases. Intern Med J 34: 270–278.
Magy, L, Mertens, C, Avellana-Adalid, Vet al. (2003). Inducible expression of FGF2 by a rat oligodendrocyte precursor cell line promotes CNS myelination in vitro. Exp Neurol 184(2): 912–922.
Marx, RE, Johnson, RP, Kline, SN (1985). Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc 111; 49–54.
McEwen, BS, Alves, SE (1999). Estrogen actions in the central nervous system. Endocr Rev 20: 279–307.
Mehta, MP, Tremont-Lukas, I (2004). Radiosurgery for single and multiple metastases. In Sawaya, R (ed.) Intracranial Metastases: Current Management Strategies, (pp. 139–164). Malden MA: Blackwell.
Mehta, MP, Shapiro, WR, Glantz, Met al. (2002). Lead-in phase to randomized trial of Motexafin Gadolinium and whole brain radiation for patients with brain metastases. Centralized assessment of magnetic resonance imaging, neurocognitive and neurologic end points. J Clin Oncol 20: 3445–3453.
Mehta, MP, Rodrigus, P, Terhaard, CHJ et al: (2003). Survival and neurologic outcomes in a randomized trial of Motexafin Gadolinium and whole brain radiation therapy in brain metastases. J Clin Oncol 21: 2529–2536.
Mehta, MP, Gervais, R, Chabot, Pet al. (2006). Motexafin gadolinium (MGd) combined with prompt whole brain radiation therapy (RT) prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a phase III trial [abstract]. Proc Am Soc Clin Oncol 24 [Suppl. 18S]: 7014.
Meyers, CA, Abbruzzese, JL (1992). Cognitive functioning in cancer patients: effect of previous treatment. Neurology 42: 434–436.
Meyers, CA, Boake, C (1993). Neurobehavioral disorders experienced by brain tumor patients: rehabilitation strategies. Cancer Bull 45: 362–364.
Meyers, CA, Hess, KR (2003). Multifaceted endpoints in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neurooncology 5: 89–95.
Meyers, CA, Valentine, AD, Wong, FCLet al. (1994). Reversible neurotoxicity of interleukin-2 and tumor necrosis factor: correlation of SPECT with neuropsychological testing. J Neuropsychiatry Clin Neurosci 6: 285–288.
Meyers, CA, Weitzner, MA, Valentine, et al. (1998). Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 16(7): 2522–2527.
Meyers, CA, JA, Smith, Bezjak, Aet al. (2004). Neurocognitive function and progression in patients with brain metastases treated with whole brain radiation and Motexafin Gadolinium: results of a randomized phase III trial. J Clin Oncol 22(1): 157–165.
Mix, JA, Crews, WD (2002). A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings. Hum Psychopharmacol 17(6): 267–277.
Monje, ML, Palmer, T (2003). Radiation injury and neurogenesis. Curr Opin Neurol 16: 129–134.
Murray, KJ, Scott, C, Greenberg, HMet al. (1997). A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 39: 571–574.
Nieder, C, Berberich, W, Schnabel, K (1997). Tumor-related prognostic factors for remission of brain metastases after radiotherapy. Int J Radiat Oncol Biol Phys 39: 25–30.
Noordjik, EM, Vecht, CJ, Haaxma-Reiche, Het al. (1994). The choice of treatment of single brain metastases should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 29: 711–717.
Nussbaum, ES, Djalilian, HR, Cho, Ket al. (1996). Brain metastases: histology, multiplicity, surgery and survival. Cancer 78(8): 1781–1788.
Patchell, RA, Tibbs, PA, Walsh, JWet al. (1990). A randomized trial of surgery in the treatment of single metastases to the brain. N Eng J Med 322(8): 494–500.
Patchell, RA, Tibbs, PA, Regine, WFet al. (1998). Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. J Am Med Assoc 280: 1485–1489.
Peace, KA, Orme, SM, Thompson, AR (1997). Cognitive dysfunction in patients treated for pituitary tumors. J Clin Exp Neuropsychol 19: 1–6.
Peissner, W, Kocher, M, Treuer, H (1999). Ionizing radiation-induced apoptosis of proliferating stem cells in the dentate gyrus of the adult rat hippocampus. Brain Res Mol Brain Res 71(1): 61–68.
Penitzka, S, Steinvorth, S, Sehlleier, Set al. (2002). Assessment of cognitive function after preventive and therapeutic whole brain irradiation using neuropsychological testing. Strahlenther Onkol 178: 252–258.
Pirzkall, A, Debus, J, Lohr, Fet al. (1998). Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 16: 3563–3569.
Posner, JB (1995). Neurologic Complications of Cancer. Philadelphia, PA: FA Davis.
Postmus, PE, Haaxma-Reiche, H, Smit, EFet al. (2000). Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy. A phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 18: 3400–3408.
Quan, AL, Videtic, GM, Suh, JH (2004). Brain metastases in small cell lung cancer. Oncology 18: 961–72.
Regine, WF, Scott, C, Murray, Ket al. (2001). Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs accelerated hyperfractionated radiotherapy: an analysis of RTOG study91–04. Int J Radiat Oncol Biol Phys 51: 711–717.
Regine, WF, Schmitt, FA, Scott, CBet al. (2004). Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018. Int J Radiat Oncol Biol Phys 58(5): 1346–1352.
Renschler, M, Mehta, MP, Donald, DMet al. (2003). Treatment intent for brain metastases: surveys of medical and radiation oncologists indicate that maintaining neurologic and neurocognitive function is more important than prolonging survival. Proc Am Soc Clin Oncol 22: 552 (no. 2222).
Rich, JB, Maki, P (1999). Estrogen, testosterone and the brain: a review of neuropsychological, aging and neuroimaging studies. J Int Neuropsychol Soc 6: iii.
Riedel, G, Reymann, KG (1996). Metabotropic glutamate receptors in hippocampal long-term potentiation and learning and memory. Acta Physiol Scand 157(1): 1–19.
Roman, G (2000). Perspectives in the treatment of vascular dementia. Drugs Today (Barc) 36(9): 641–653.
Salminen, E, Porten, R, Korpela, Jet al. (2003). Androgen deprivation and cognition in prostate cancer. Br J Cancer 89: 971–976.
Sanghavi, SN, Miranpuri, SS, Chappell, Ret al. (2001). Radiosurgery for patients with brain metastases: a multi-institutional analysis stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 51: 426–434.
Sawaya, R, Bindal, R (2001). Metastatic brain tumors. In Laws, E, Kaye, AH (eds.) Brain Tumors: an Encyclopedic Approach (pp. 923–946). Edinburgh: Churchill Livingstone.
Schagen, SB, vanDam, FS, Muller, MJet al. (1999). Cognitive deficits after postoperative chemotherapy for breast cancer. Cancer 85: 640–650.
Scheibel, RS, Meyers, CA, Levin, VA (1996). Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location and treatment. J Neurooncol 30: 61–69.
Schellinger, PD, Meinck, HM, Thron, A (1999). Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol 44(3): 275–281.
Schultheiss, TE, Kun, , Ang, KKet al. (1995). Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 31: 1093–1112.
Senzer, N (2002). Rationale for a phase III study of erythropoietin as a neurocognitive protectant in patients with lung cancer receiving prophylactic cranial irradiation. Semin Oncol 6 [Suppl. 19]: 47–52.
Seung, SK, Sneed, PK, McDermott, MWet al. (1998). Gamma Knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am 4: 103–109.
Shaw, E, Scott, C, Suh, Jet al. (2003). RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group recursive partitioning analysis brain metastases database. J Clin Oncol 21: 2364–2371.
Sheline, GE, Wara, WM, Smith, V (1980). Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6: 1215–1228.
Silverman, DH, Castellon, SA, Abraham, Let al. (2003). Abnormal regional brain metabolism in breast cancer survivors after adjuvant chemotherapy is associated with cognitive changes. Proc Am Soc Clin Oncol 22: 12.
Sundstrom, JT, Minn, H, Lertola, KKet al. (1998). Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann Med 30: 296–299.
Taphoorn, MJB (2003). Neurocognitive sequelae in the treatment of low grade gliomas. Semin Oncol 30 [6 Suppl. 19] 45–48.
Tucha, O, Smely, C, Preier, M (2003). Preoperative and postoperative cognitive functioning in patients with frontal meningioma. J Neurosurg 98: 21–31.
Turkheimer, E, Yeo, RA, Jones, CLet al. (1990). Quantitative assessment of covariation between neuropsychological function and location of naturally occurring lesions in human. J Clin Exp Neuropsychol 12: 549–565.
Kogel, AJ (1986). Radiation-induced damage in the central nervous system: an interpretation of target cell responses. Br J Cancer 7: 207–217.
Oosterhout, AG, Boon, PJ, Houx, PJet al. (1995). Follow up of cognitive functioning in patients with small cell lung cancer. Int J Radiat Oncol Biol Phys 31: 911–914.
Vannucci, RC, Baten, M (1974). Cerebral metastatic disease in childhood. Neurology 24(10): 981–985.
Varney, NR, Syrop, C, Kubu, CSet al. (1998). Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism. J Assist Reprod Genet 10: 53–57.
Verger, E, Gil, M, Yaya, Ret al. (2003). Concomitant temozolomide (TMZ) and whole brain radiotherapy (WBRT) in patients with brain metastases (BM): randomized multicentric phase II study [abstract]. Proc Am Soc Clin Oncol 22: 101.
Wefel, JS, Kayl, AE, Meyers, CA (2004a). Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target. Br J Cancer 90: 1691–1696.
Wefel, JS, Lenzi, R, Theriault, RLet al. (2004b). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective randomized longitudinal trial. Cancer 100(11): 2292–2299.
Weitzner, MA, Meyers, CA, Valentine, AD (1995). Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment. J Neuropsychiatry Clin Neurosci 7: 347–350.
Wen, PY, Black, PM, Loeffler, JS (2001). Metastatic brain cancer. In Devita, VT, Hellman, S, Rosenberg, SA (eds.) Cancer: Principles and Practice of Oncology (6th edn.) (pp. 2655–2670). Philadelphia PA: Lippincott Williams & Wilkins.
Wieneke, MH, Dienst, ER (1995). Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology 4: 61–66.
Wolkowitz, OM, Reus, VI, Weingartner, Het al. (1990). Cognitive aspects of corticosteroids. Am J Psychiatry 147: 1297–1303.
Young, RF (1998). Radiosurgery for the treatment of brain metastases. Semin Surg Oncol 14: 70–78.
Zimm, S, Wampler, GL, Stablein, Det al. (1981). Intracerebral metastases in solid tumor patients: natural history and results of treatment. Cancer 48: 384–394.